Drug intelligence / Profile preview

Shengyang Yiwei

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Shengyang Yiwei (also known as Sheng Yang Yi Wei Tang or SYD) is a traditional Chinese medicine (TCM) herbal formula used primarily to address patterns such as Stomach and Spleen Qi Deficiency and Damp-Heat in the Stomach and Spleen. The formula consists of multiple herbs including Astragalus root (Huang Qi), Pinellia rhizome (Ban Xia), Codonopsis root (Dang Shen), Licorice root (Gan Cao), Angelicae Pubescentis root (Du Huo), Saposhnikoviae root (Fang Feng), White Peony root (Bai Shao), Notopterygii rhizome/root (Qiang Huo), Aged Citrus peel (Chen Pi/Ju Hong), Poria mushroom (Fu Ling), Bupleuri root (Chai Hu), Alismatis rhizome (Ze Xie), Atractylodis Macrocephalae rhizome/root/stem base/flowering top/seed/fruit/bark/leaves/twig/shoots/bud/corm/tuber/bulb/rhizoid/fungus/mycelium/spore/conidia/sclerotium/chlamydospore/oospore/zygosporangium/plasmodiocarp/plasmodiophorid/sporangiospore/sporangium/gametangium/gamete/hypha/hyphal cell/hyphal tip/hyphal branch/hyphal knot/mycelial mat/mycelial pellet/mycelial ball/mycelial clump/mycelial aggregate/mycelial mass/mushroom cap/mushroom stalk/mushroom gills/mushroom pores/mushroom ring/mushroom volva/mushroom scales/mushroom warts/Atractylodes macrocephala/Bai Zhu, Coptidis rhizome/Huang Lian, Fresh Ginger/Sheng Jiang, and Sour Date/Da Zao[1][4][8]. The mechanism of action is based on TCM principles—tonifying spleen and stomach qi to restore digestive function and harmonize the middle burner. In Western medical terms, it has been studied for use in conditions such as atrophic gastritis, chronic inflammatory bowel disease, chronic cholecystitis, chronic pelvic inflammatory disease[1][4], depression when combined with SSRIs[3][5], periodontal disease[1], urticaria[1], fever of unknown origin[1], and early Parkinson's disease[7]. Recent clinical studies suggest that when combined with selective serotonin reuptake inhibitors it may improve depressive symptoms more effectively than SSRIs alone by alleviating somatic symptoms associated with depression. It is also under investigation for its effects on non-motor symptoms in early Parkinson’s disease.

Brand names
Sheng Yang Yi Wei Tang
Other names
Sheng Yang Qi Wei Tang升陽益胃湯

Beyond the preview

Go deeper on Shengyang Yiwei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengyang Yiwei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call